Jason Yongsheng Chan

42PUBLICATIONS
141CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 02, 2026
Advances in molecular pathobiology of PCNSL - towards clinical implementation of novel diagnostics and therapeutics.

|Sep 21, 2026
A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.

|Aug 20, 2026
Clinical and hematological indices as prognosticators in localized solitary fibrous tumors: A retrospective study.

|Jun 02, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Jan 16, 2026
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Alex Y Ge, William B Feldman, Martin F Kaiser

Pageof 7

Frequent Collaborators

9 joint publications

Choon Kiat Ong

8 joint publications

Jing Han Hong

8 joint publications

Bin Tean Teh

7 joint publications

Peiyong Guan